We scan new podcasts and send you the top 5 insights daily.
Blue Moon passed on Perplexity's $90M round due to strict price discipline and lack of time for deep diligence. This highlights how rigid adherence to valuation can lead to missing out on category-defining companies, especially in rapidly evolving markets like early AI where standard metrics may not apply.
Unlike large multi-stage funds that can afford to overpay due to their AUM and fund structure, alpha-focused early-stage VCs must remain disciplined on entry prices. Their model cannot sustain winning deals by simply paying more.
Citing a quote from legendary investor Jim Breyer, Miles Clements emphasizes that while the science of VC is valuation, the art is knowing when to ignore it. He shares that Accel missed investing in ServiceTitan, a $9B company, by rigidly adhering to valuation multiples for vertical SaaS, learning a costly lesson about the need for flexibility with generational founders.
An investor passed on a fund that paid 30-40x revenue for startups, believing quality alone justifies price. Three years later, that fund and its predecessors are underwater. This illustrates that even for great companies, undisciplined entry valuations and the assumption of multiple expansion can lead to poor returns.
The AI fundraising environment is fueled by investors' personal use of the products. Unlike B2B SaaS where VCs rely on customer interviews, they directly experience the value of tools like Perplexity. This firsthand intuition creates strong conviction, contributing to a highly competitive investment landscape.
AI companies raise subsequent rounds so quickly that little is de-risked between seed and Series B, yet valuations skyrocket. This dynamic forces large funds, which traditionally wait for traction, to compete at the earliest inception stage to secure a stake before prices become untenable for the risk involved.
Paul Madera of Meritech passed on Palantir four times. Despite being introduced early, his firm repeatedly concluded the price was "out of line," causing them to miss what became the highest multiple software company. This shows how strict valuation discipline can blind investors to category-defining outliers.
This provides a simple but powerful framework for venture investing. For companies in markets with demonstrably huge TAMs (e.g., AI coding), valuation is secondary to backing the winner. For markets with a more uncertain or constrained TAM (e.g., vertical SaaS), traditional valuation discipline and entry price matter significantly.
Andreessen reflects that, specifically in early-stage venture, his firm's decisions to pass on promising companies because the valuation was too high have consistently proven to be mistakes. For the best opportunities, the potential for massive upside makes the entry price a secondary concern.
For promising venture-stage companies, price sensitivity is a losing strategy. The truly exceptional opportunities attract significant interest, driving up valuations. According to Andreessen, the mistake of omission (passing on a future giant) far outweighs the mistake of overpaying slightly for a winner.
The founder advises against always pursuing the highest valuation, noting it can lead to immense pressure and difficulties in subsequent rounds if the market normalizes. Prioritizing investor chemistry and a fair, responsible valuation is a more sustainable long-term strategy.